Alnylam s Maraganore on Leaving Millennium to Guide an RNAi Therapeutics Startup

Sep 19, 2003

Premium

At A Glance

Name: John Maraganore

Age: 40

President and CEO

Senior Vice President of Strategic Product Development at Millennium—1999–2002

General Manager at Millennium BioTherapeutics—1997–1999

Director of Molecular Biology, Director of Market and Business Development at Biogen—1987–1997

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

All About the Proteins

The New York Times Magazine writes that proteomics might be better poised than genomics to say when someone is falling ill.

Lab Space and a Dream

Bloomberg profiles IndieBio, a startup incubator for the life sciences.

"Must Stop"

In an editorial, Nature calls for the end to the exploitation of foreign postdocs.

This Week in Nucleic Acids Research

In Nucleic Acids Research this week: collection of epigenome-wide association study data, updated BloodSpot database, and more.

Featured White Papers

Tissue Section Imaging

In Vivo Validation of Optical Probes

Ex Vivo Imaging Quick Start Guide

Probe Design and In Vitro Validation Quick Start Guide

Dec

03

Featured Webinar

Application of a Novel ISH Approach to Elucidate Splice Variants in Schizophrenia

This webinar will demonstrate how a research team at the National Institutes of Health evaluated a novel in situ hybridization approach and applied it to study splice variants related to schizophrenia.

Dec

04

Featured Webinar

Clinical-Grade Exome Analysis for Complex and Unsolved Case Investigations

This webinar will discuss the use of clinical-grade exome analysis application in complex case investigations.

Main menu